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When mitochondrial respiration is compromised, the
F1Fo-ATP synthase reverses and consumes ATP,
serving to maintain the mitochondrial membrane
potential (Dcm). This process is mitigated by IF1. As
little is known of the cell biology of IF1, we have in-
vestigated the functional consequences of varying
IF1 expression. We report that, (1) during inhibition
of respiration, IF1 conserves ATP at the expense of
Dcm; (2) overexpression of IF1 is protective against
ischemic injury; (3) relative IF1 expression level varies
between tissues and cell types and dictates the re-
sponse to inhibition of mitochondrial respiration; (4)
the density of mitochondrial cristae is increased
by IF1 overexpression and decreased by IF1 sup-
pression; and (5) IF1 overexpression increases the
formation of dimeric ATP synthase complexes and
increases F1Fo-ATP synthase activity. Thus, IF1 regu-
lates mitochondrial function and structure under
both physiological and pathological conditions.
INTRODUCTION
Mitochondrial oxidative phosphorylation is central to the organi-
zation of eukaryotic life. At the heart of mitochondrial energy
transduction is the F1Fo-ATP synthase, a transmembranemolec-
ular motor driven by the electrochemical potential (Dcm) estab-
lished across the inner mitochondrial membrane by respiration
(Moyle and Mitchell, 1973; Abrahams et al., 1994; Boyer,
1997). When Dcm is compromised, for example during oxygen
deprivation or in response to damage or mutations of mitochon-
drial respiratory proteins, the thermodynamic equilibrium favors
the reversed activity of the enzyme (Figure 1A). The enzyme may
then act as a proton motive ATPase (Zanotti et al., 1987; Jen-
nings et al., 1991) consuming ATP and translocating protons
from the mitochondrial matrix (Nicholls and Lindberg, 1972).
This activity maymaintain Dcm in the face of impaired respiration
(Hatefi, 1985) as long as there is provision of glycolytic ATP.This process may be regulated by a nuclear encoded protein,
the inhibitor factor 1 (IF1) (Harris et al., 1979; Schwerzmann and
Pedersen, 1986; Hashimoto et al., 1990; Green and Grover,
2000). The protein was identified in 1963 (Pullman and Monroy,
1963), and its molecular structure and activity have been charac-
terized in detail (Cabezon et al., 2000a, 2001, 2003; Gledhill et al.,
2007), but its cell biology has not been systematically explored. A
protein of 84 amino acids (10 kDa), its expression or that of
homologous inhibitory proteins has been documented in mam-
mals, flies, plants, and yeast, showing little variation in size and
sequence (Cintron and Pedersen, 1979; Norling et al., 1990; Har-
ris and Das, 1991; Cabezon et al., 2002; Ichikawa et al., 2006).
Studies of isolated enzymes have shown that IF1 binding to the
F1Fo complex and inhibition of ATPase activity are favored by
an acidic pH, with an optimum inhibition of hydrolysis between
pH 6.5–6.7 (Cabezon et al., 2000a). The resultant F1-IF1 complex
inhibits ATPase activity by up to 85%–90%, conserving ATP dur-
ing ischemic conditions (Atwal et al., 2004; Di Pancrazio et al.,
2004). Here, we show in intact cells that changing the expression
level of IF1 directly alters ATPase activity and resultant changes
in Dcm during inhibition of mitochondrial respiration. As a conse-
quence, varying the expression level of IF1 experimentally deter-
mines the degree of cell injury in response to hypoxia. We also
show that the expression level of the protein relative to the b sub-
unit of the ATPase (to which IF1 binds) varies substantially be-
tween tissues and even between cell types within tissues. It
therefore seems plausible that IF1 expression levels may contrib-
ute to define the selective vulnerability of different tissues to
hypoxic injury.
It has been suggested that the F1Fo-ATP synthase plays
a scaffolding role in the inner mitochondrial membrane, deter-
mining cristae structure (Paumard et al., 2002; Giraud et al.,
2002; Minauro-Sanmiguel et al., 2005; Strauss et al., 2008).
The ATP synthase seems to form dimeric arrays in the inner
membrane of yeast and mammalian mitochondria (Buzhynskyy
et al., 2007; Strauss et al., 2008), and it has been suggested
that IF1 promotes ATP synthase dimerization (Garcia et al.,
2006), although this remains controversial (Tomasetig et al.,
2002; Dienhart et al., 2002). We have therefore explored the
impact of IF1 expression on mitochondrial structure and found
that altered IF1 expression is associated with altered density ofCell Metabolism 8, 13–25, July 2008 ª2008 Elsevier Inc. 13
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Regulation of Mitochondrial Structure and Function by IF1mitochondrial cristae. Furthermore, our data suggest that in-
creased expression of exogenous IF1 promotes coupling of the
F1Fo-ATP synthase, increasing H
+ flux and NADH oxidation,
showing that IF1 modulates resting mitochondrial structure and
function in mammalian cells.
RESULTS
The Expression Level of IF1 Varies between Tissues
and Cell Types
The intracellular localization of IF1 with respect to the ATP syn-
thase was investigated using coimmunofluorescence of IF1 and
the mitochondrial ATP synthase b subunit, to which IF1 binds
(Ichikawa et al., 2005). IF1 localized exclusively to the mitochon-
dria in C2C12 (Figure 1B), HeLa (Figure S1A), HL-1, HepG2, and
BV2 cells (data not shown) as well as in primary cultures of cor-
tical neurons and astrocytes (see below). A representative con-
focal image showing the immunofluorescence in C2C12 cells is
shown in Figure 1B, with a colocalization index of 93% ± 0.6%
(see also Figure S1A).
We also investigated the ratio of expression of IF1 and the
b subunit among several tissues of the mouse. Rouslin (Rouslin
et al., 1995) suggested that the activity of IF1 in the heart varies
between species, but levels of the protein were not established.
We therefore used semiquantitative western blots to measure
the IF1 expression level compared to that of the b subunit of
the ATP synthase in murine tissues and in cells of murine origin
(HL-1 and C2C12). This approach showed that relative IF1
expression levels varied considerably between tissues (Fig-
ure 1C) and that it was endogenously more highly expressed in
cardiac ventricular myocytes relative to the b subunit of the
ATPase than in other tissues examined. This was seen both in
primarymouse ventricle and in the cardiomyocyte cell line, HL-1.
In addition, a greater ratio of expression was apparent in all im-
mortalized cell lines tested compared to levels in the primary
tissues from which they were derived (see Bravo et al., 2004).
The Expression Level of IF1 Determines the Rate
of Change of Dcm following Inhibition of Respiration
Most published data concerning the action of IF1 are derived
from biochemical experiments on isolated enzymes or mito-
chondrial fractions. We therefore used genetic approaches to
modulate IF1 expression level in a heterologous system and to
characterize its functional contribution to the response to inhibi-tion of respiration in intact cells. IF1 was overexpressed using re-
combinant cDNA or suppressed by small interfering RNA (siRNA)
in HeLa and in C2C12 cells (Figures 1D and S1B). The efficacy of
the genetic manipulations was confirmed by immunofluores-
cence and western blot analysis. We then examined the impact
of IF1 expression on the proton pumping activity of the ATPase in
intact cells by measuring changes in Dcm following inhibition of
respiration by sodium cyanide (NaCN) (Figure 1E). When respira-
tion is inhibited, the rate of dissipation of Dcm depends on the
proton leak opposed by the proton pumping activity of the
ATPase. NaCN caused the progressive loss of Dcm in control
C2C12 cells. The extent of mitochondrial depolarization was
greater in cells overexpressing IF1, while in cells in which IF1 ex-
pression was suppressed, the potential was sustained at a new
steady state—i.e., ATPase activity in these cells maintained
the potential that was finally dissipated by addition of either
carbonylcyanide-p-trifluoromethoxyphenylhydrazone (FCCP)
or of oligomycin, the F1Fo-ATP synthase inhibitor (see also
Figure S2B). Changes in Dcm were also measured using rhoda-
mine 123 in the ‘‘dequench mode’’ (Duchen et al., 2003),
whereby mitochondrial depolarization is signaled by an increase
in fluorescence (Figure S1C). Identical analysis in HeLa cells
(Figure S2) confirmed these results, demonstrating their inde-
pendence of cell type. These data demonstrate that the inhibi-
tion of mitochondrial F1Fo-ATP synthase activity is increased
by IF1 overexpression, while reduction of IF1 expression permits
reversal of the mitochondrial F1Fo-ATP synthase that consumes
ATP and preserves Dcm.
IF1 Limits Mitochondrial ATP Consumption and Protects
Cells from Ischemic Cell Death
The corollary of the previous experimentwas tomonitor themod-
ulation of ATP consumption in relation to the IF1 expression level.
The rate of mitochondrial ATP consumption wasmeasured using
the ATP-dependent cytosolic photoprotein luciferase, cyt-LUC.
Luminescence was measured from cyt-LUC transfected C2C12
cells in the presence of 50 mM luciferin. The cells were exposed
to FCCP (1 mM) to collapse Dcm and promote maximal activity
of the ATPase. In cells in which IF1 expression was suppressed,
[ATP] fell rapidly (gray trace), while in control cells (black trace),
[ATP] was maintained (Figure 2A, i). These observations suggest
that following suppression of IF1 expression, ATPase activity is
sufficient to promote significant [ATP] consumption, while en-
dogenous IF1 may be sufficient to limit significant bulk [ATP]Figure 1. Relative IF1 Expression Varies among Tissues and Shapes Dcm Dissipation during Inhibition of Respiration
(A) Mitochondrial respiration generates a potential (Dcm), which drives the ATP synthase (i). When Dcm collapses, the equilibrium favors the reverse mode of the
enzyme, which acts as a proton motive ATPase to maintain Dcm. This mechanism is inhibited by IF1 (ii).
(B) Confocal image showing the immunofluorescence to IF1 (red) and the ATPase b subunit (green) in C2C12 cells. The two antibodies colocalize exclusively to
mitochondria.
(C) Quantitative western blots showing the relative expression of IF1 and ATPase b subunit between tissues. (i) shows the ratio of IF1 to b subunit in selected
mouse tissues and mouse-derived cell lines. Mean ratios (±SD) were the following: heart, 2.61 ± 0.5; lung, 1.67 ± 0.32; liver, 1.21 ± 0.5; HL-1, 5.76 ± 0.5;
C2C12, 2.94 ± 0.35 (n = 3, ** = p < 0.005). (i) shows Representative western blots for IF1 and the b subunit.
(D) Genetic manipulation of IF1 expression is effective in C2C12 cells. In (i), cells were cotransfected with EYFP (shown green) and recombinant IF1. Immunoflu-
orescence to IF1 (+IF1, red) shows increased IF1 expression in transfected (green) cells compared to untransfected neighbors. In (ii), cells cotransfected with GFP
and the siRNA to knock down IF1 (IF1) show reduced IF1 expression. In (iii), values (mean fluorescence intensity ± SD) from three different transfections are
summarized. Control, 1033.15 ± 340.33, arbitrary units (au); +IF1: 2466.25 ± 822.11 au; IF1: 516.1 ± 83.64 au (n = 28, ***p < 0.001).
(E) The dissipation of Dcm in response to NaCN (1mM) was measured in +IF1 and IF1 cells using TMRM. In (i), the collapse of Dcm was increased in +IF1 cells
(gray filled circles) compared to control (black dots), while Dcm was sustained inIF1 cells (gray triangles). Normalized values (mean ± SD) recorded at 30 min of
NaCN treatment are shown in (ii), where 1 is the resting value and 0 represents complete collapse of potential (control, 0.47 ± 0.04; +IF1, 0.21 ± 0.02,IF1, 0.67 ±
0.06; n = 36, 4 distinct days of experiment; ***p < 0.001).Cell Metabolism 8, 13–25, July 2008 ª2008 Elsevier Inc. 15
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(A) In (i), C2C12 cells cotransfected with cyt-Luc and mtGFP (black trace) or siRNA for IF1 (gray trace) were exposed to Luciferin (50 mM) and 1 mM FCCP
added to dissipate Dcm and promote maximal ATPase activity. (ii) shows that in control cells, FCCP did not significantly change [ATP], while IF1 cells showed
a significant decrease in [ATP], which was blocked by oligomycin (2.5 mg/ml), confirming the role of the F1Fo-ATP synthase in ATP consumption. Mean ± SD nor-
malized values at 15min after FCCP addition are summarized in (ii). Control, 0.84 ± 0.04, n = 6,IF1 = 0.56 ± 2.15, n = 8, *p < 0.05IF1 with olig.0.79 ± 0.04, (n = 7,
p = 0.101).16 Cell Metabolism 8, 13–25, July 2008 ª2008 Elsevier Inc.
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the F1Fo-ATP synthase was confirmed as the [ATP] consumption
promoted by FCCP in siRNA transfected cells (Figure 2A, ii) was
significantly reduced by oligomycin (2.5 mg/ml).
The impact of IF1 expression level on mitochondrial ATP con-
sumption was also assessed in single cells (Figure 2B). Free
cytosolic magnesium concentration ([Mg2+]c) was monitored as
an index of ATP consumption: Mg2+ is released following ATP
hydrolysis, as the affinity of ATP for Mg2+ is significantly greater
than that of ADP (Leyssens et al., 1996). [Mg2+]c was measured
using Mag-fura in control or IF1 siRNA treated HeLa cells follow-
ing exposure to iodoacetic acid (IAA) to inhibit glycolysis and
NaCN to block mitochondrial respiration. This caused a progres-
sive increase in [Mg2+]c, leading eventually to cell lysis—seen as
an abrupt decrease in signal that reflects ATP depletion and loss
of dye with cell lysis (Figure 2B, i). The absolute value of the in-
crease in Mag-fura signal at the time of lysis is complicated by
the sensitivity of the Mag-fura to high [Ca2+]c, as [Ca
2+]c rises
with lysis. However, the rate of increase of [Mg2+]c, correspond-
ing to the rate of ATP depletion, was significantly greater and the
time taken to ATP depletion and cell lysis significantly shorter in
siRNA treated compared to control cells (Figure 2B, i and iii). In-
hibition of the F1Fo-ATP synthase by oligomycin (2.5 mg/ml) de-
creased the rate of [Mg2+]c increase, cell lysis was significantly
delayed in both control and IF1 cells, and there was no longer
any significant difference in the time to ATP depletion between
control and IF1 cells (Figure 2B, ii and iii). These observations
confirm the role of the F1Fo-ATP synthase in driving ATP con-
sumption and the role of IF1 as a modulator of ATP consumption
under these conditions.
In order to assess the role of IF1 on cell death induced by ATP
depletion under pathological conditions, we explored the impact
of IF1 expression level on cell fate following exposure to depriva-
tion of oxygen and glucose in C2C12 and HeLa cells. Control
cells or cells with modified expression levels of IF1 were exposed
to a glucose-free medium in an anoxic chamber for 20 min fol-
lowed by 30 min of reoxygenation. Cell death was quantified
using propidium iodide (PI) to label dead cells and Hoechst to
identify all nuclei (see Experimental Procedures). Cells overex-
pressing IF1 were significantly protected, while cell death was
significantly increased in cells in which IF1 expression was sup-
pressed (Figure 2C), showing that IF1 plays a protective role in
experimental conditions that model ischemic injury.
Relative IF1 Expression Differs in Neurons and Astroglia
and Dictates Different Responses to Inhibition
of Respiration
Neurons are highly oxidative, while astrocytes have a greater gly-
colytic capacity (Peuchen et al., 1996;Magistretti, 2006). In orderto explore the expression levels of IF1 relative to the b subunit of
the ATP synthase in different cell types, we used quantitative
immunofluorescence to examine the expression levels of the
two proteins in hippocampal cocultures containing both neurons
and astrocytes. Neurons showed a significantly higher level of
IF1 relative to the b subunit of the ATPase than astrocytes, show-
ing a ratio of IF1 immunofluorescence signal relative to that of the
b subunit of the ATPase of1.45, while the ratio was0.8 in ad-
jacent astrocytes (Figure 3A). As the two cell types are exposed
to identical conditions, differences in signal can only be due to
cell-specific differences in IF1 expression. The functional impact
of the difference in IF1 expression was explored by following
changes in Dcm in response to inhibition of mitochondrial respi-
ration. Dcm was measured using rhodamine 123 in the ‘‘de-
quench mode’’ (see above) in which the collapse of Dcm in-
creases the fluorescence signal (see Experimental Procedures)
(Duchen et al., 2003). Inhibition of respiration with NaCN caused
the progressive loss of Dcm in neurons (Figure 3B, i), while Dcm
wasmaintained at a new steady state in astrocytes (Figure 3B, ii).
The maintenance of Dcm was attributable to the ATPase, as
Dcm collapsed rapidly in both cell types in response to NaCN
in the presence of oligomycin (2.5 mg/ml; Figure 3B, iii and iv).
Thus, there are significant differences in the relative expression
levels of IF1 in different populations of primary mammalian cells
with distinct metabolic properties, differences that dictate the
cellular responses to inhibition of respiration.
IF1 Overexpression Increases Mitochondrial Cristae
Formation and Dimerization of F1Fo-ATP Synthase
The ATP synthase is thought to play a role in determining mito-
chondrial cristae formation (Giraud et al., 2002; Paumard et al.,
2002;Strausset al., 2008). It hasalsobeen suggested that IF1 pro-
motes the dimerization of ATPase complexes (Cabezon et al.,
2000b; Garcia et al., 2006). In order to investigate this association
further, we explored the mitochondrial ultrastructure of control,
+IF1 and IF1 cells cotransfected with mtGFP using electron
microscopy (EM). GFP-transfected cells were identified using
fluorescence microscopy, marked, and selected for EM study.
EM images showed that mitochondria in +IF1 cells were densely
packed with cristae and invaginations and showed a more
elongated morphology compared to controls. In contrast, the in-
ner membrane of mitochondria in IF1 cells was disorganized,
with very limited cristae (Figure 4A, i and ii). Quantification of these
data confirmed significant differences in the number of cristae
per mitochondrion, the density of cristae per unit area of the
image, and the relative volume of a mitochondrion occupied by
cristae.
In order to determine whether dimerization of the ATP syn-
thase complexes was influenced by IF1 expression level, we(B) In (i), measurements of [Mg2+]c indicate the rate of ATP consumption following inhibition of ATP synthesis. Control (black trace) andIF1 (gray trace) Mag-fura
loaded HeLa cells were exposed to iodoacetic acid (IAA) and NaCN (1 mM), inducing a progressive increase in [Mg2+]c that culminated in cell lysis (abrupt loss of
signal due to ATP depletion). In (ii), the rate of rise of [Mg2+]c was increased in IF1 cells compared to control, and cell lysis was earlier. Oligomycin (2.5 mg/ml)
abolished the difference between control andIF1 cell,s and cell lysis was significantly delayed. In (iii), summarized data showing the time (means ± SD) required
for ATP depletion are depicted: NaCN + IAA; control, 57.5 ± 5.4 min, n = 63 cells; IF1, 42.8 ± 3 min, n = 79 cells; Olig + IAA, control, 62.3 ± 2.5 min, n = 32 cells;
IF1: 61.4 ± 3.5 min, n = 43 cells; ***p < 0.001 (from 2 different days of experiment). C2C12 and HeLa cells 36 hr after transfection were deprived of oxygen and
glucose (OGD) as described and cell death quantified using PI and Hoechst 33258.
(C) In (i), representative images of untreated and treated HeLa cells are shown. (ii) results are expressed as a percentage of cell death relative to control, normal-
ized to 100% (C2C12, +IF1: 62.84 ± 7.53, IF1: 132.93 ± 14.16; HeLa, +IF1: 55.25 ± 12.02, IF1: 114.24 ± 3.88, **p < 0.005. Data are mean ± SD of four exper-
iments run in triplicate).Cell Metabolism 8, 13–25, July 2008 ª2008 Elsevier Inc. 17
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dimeric form of the ATP synthase in control and IF1-overexpress-
ing cells. BN-PAGE enables separation of protein complexes
from organelles or membrane fractions, keeping their composi-
tion, properties, and enzymatic activities unchanged. Figure 4B
illustrates a characteristic BN-PAGE/SDS-PAGE of control and
IF1-transfected HeLa cells. Rat heart mitochondria were used
to calibrate the BN gel, where respiratory chain complexes
were used as molecular weight markers. The monomeric and di-
meric forms of the ATPase were localized using specific anti-
bodies on the BN-PAGE after the second dimension SDS-
PAGE. Comparison of control and +IF1 cells shows evident dif-
ferences in the intensity of the spot corresponding to the dimeric
form of the ATPase with relation to the monomeric form
(Figure 4B, ii). Quantification of the blot showed that the ratio be-
tween the monomeric and dimeric form of the ATPase was de-
creased 2-fold in +IF1 cells, demonstrating a significant increase
in the dimeric form. Thus, increased IF1 expression promotes
the dimerization of the ATP synthase, consistent with the idea
that increased dimerization may influence mitochondrial cristae
formation.
IF1 Expression Level Alters the Coupling of the F1Fo-ATP
Synthase in Resting Cells
The data presented above clearly indicate that IF1 plays a more
fundamental and complex role in mitochondrial biology than op-
erating as an ATPase inhibitor under pathological conditions.
However, the impact of IF1 expression level on mitochondrial
function in relation to resting cell physiology remained unex-
plored. Measurements of Dcm using TMRM in control, +IF1, and
IF1 cells showed that Dcmwas reduced in cells overexpressing
IF1 compared to neighboring untransfected cells, whileDcm was
increased in cells in which IF1 was suppressed (Figure 5A, i).
Thus, increased IF1 expression reduces and IF1 suppression in-
creases Dcm.
It has recently been suggested that dimerization of the ATP
synthase by IF1 may improve enzyme efficiency (Garcia et al.,
2006; Strauss et al., 2008). As an increased proton flux through
the ATP synthase may reduce Dcm, we considered that this
could account for our observations. Therefore +IF1 and IF1
cells were exposed to 2.5 mg/ml oligomycin to inhibit ATP syn-
thase activity. As a result of ongoing respiration, the continued
efflux of protons increases Dcm (Figure 5A, ii). Oligomycin in-
creased Dcm in all cell groups, but the increase was smaller inIF1 positive cells and larger in +IF1 cells so that in all cell groups,
Dcm eventually reached an equivalent steady state level. When
Dcm was measured 30 min after exposure to oligomycin, values
between cell populations were no longer significantly different.
Thus, the differences in Dcm are attributable to differences in
ATP synthase activity, suggesting that IF1 modulates the activity
of the ATP synthase (Figure 5B).
If this interpretation is correct, oxygen consumption should be
higher in +IF1 cells and lower than control in -IF1 cells. As we can-
not measure oxygen consumption in single cells and measure-
ments from the population may be misleading (given a modest
transfection efficiency), we used NADH autofluorescence as an
index of redox state (see Experimental Procedures). NaCN and
FCCP were used to define the resting level in relation to maxi-
mally reduced and maximally oxidized signals respectively, giv-
ing a ‘‘redox index’’ as a measure of the resting state of the
NAD+/NADH pool (Figure 5C). Consistent with the data shown
above, the redox index was more oxidized in +IF1 cells and
more reduced in IF1 cells (Figure 5C, ii). We used oligomycin
to determine whether such differences were attributable to dif-
ferences in F1Fo-ATP synthase activity. Oligomycin increased
NADH fluorescence, consistent with the inhibition of proton in-
flux and inhibition of ATP synthase-dependent respiration, and
normalized the redox index for each cohort of cells, which
were no longer significantly different (Figure 5C, ii). These data
strongly suggest that IF1 modulates the resting proton flux
through the ATP synthase.
The corollary of these observations should be that oxidative
phosphorylation plays a greater part in the maintenance of ATP
in IF1-overexpressing cells. We therefore measured this directly
using HeLa cells cotransfected with cyt-Luc andmt-GFP as con-
trol (black trace) or cyt-Luc and IF1 (gray trace), and perfused
with 50 mM luciferin. Blockade of the ATP synthase by oligomycin
caused a slow progressive decrease of ATP in control cells, but
the decrease was significantly greater in +IF1 cells than in con-
trols (Figure 5D), suggesting that in these cells, the relative de-
pendence of ATP homeostasis is shifted in favor of oxidative
phosphorylation.
DISCUSSION
We have shown that IF1 modulates the efficiency of the F1Fo-
ATP synthase, both in forward and reverse modes, inhibiting
ATPase activity but apparently promoting synthase activity.Figure 3. Differences in the Endogenous Expression Level of IF1 in Neurons and Astrocytes in Coculture Determine Different Rates of Dcm
Dissipation in Response to NaCN
(A) Immunohistochemical analysis of IF1 expression relative to the ATPase b subunit in cocultures of astrocytes and neurons from rat hippocampus. IF1 (red) was
expressed at higher levels in neurons (identified by anti-MAP 2 antibodies). (i) compared to astrocytes (identified by antibodies to glial fibrillary acidic protein
(GFAP); [ii]. (iii) shows costaining with the ATPase-b subunit (green) and IF1 (red): the level of staining for the ATPase b subunit was equivalent in the two cell types,
while IF1 was expressed at higher levels in neurons than in astrocytes. (iv) shows themean fluorescence intensity (au) ± SD: astrocytes, b subunit: 933.79 ± 227.98
(au), IF1: 684.6 ± 139.33, neurons (au), b subunit: 1019.48 ± 210.13 (au), IF1: 1463.04 ± 358.75 (au), **p < 0.005 from three different preparations; neurons = 72,
astrocytes = 87.
(B) The rate ofDcmdissipation in response toNaCNwasmeasured using Rh123. Datawere normalized between 0 for baseline and 100% representing dissipation
of Dcm with FCCP. (i) shows that, in neurons, Dcm progressively collapsed during exposure to NaCN reaching a normalized mean value (± SD) of 84.61 ± 23.6
at 15 min of exposure to NaCN (data from 4 different experiments, n = 36 cells). (ii) shows that in neighboring astrocytes, NaCN caused a small loss of Dcm,
which was maintained at a new steady state reaching a normalized mean signal (± SD) of 30.30 ± 9.55 at 15 min (four different experiments, n = 44 cells). (iii) and
(iv) show that in the presence of 2.5 mg/ml oligomycin, Dcm collapse in response to NaCN occurred at the same rate in both neurons and astrocytes. Mean
normalized signals (± SD) at 15 min of NaCN exposure were 95.81 ± 2.35 in neurons and 96.00 ± 2.70 in astrocytes (four different experiments, neurons = 16,
astrocytes = 21).Cell Metabolism 8, 13–25, July 2008 ª2008 Elsevier Inc. 19
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Dimerization
(A) Mitochondrial ultrastructure was explored using EM in identified HeLa cells expressing mtGFP (control) andmtGFP together with either recombinant IF1 (+IF1)
or siRNA for IF1 (IF1). In (i), mitochondrial EM images are at differentmagnification for each (images representative of five preparations) In (ii), quantification of the
intramitochondrial volume occupied by cristae, the number of cristae per mitochondrion, and the density of cristae as occupancy per 1 mm2 (volume fraction
occupied by cristae expressed in percent; control, 34.31 ± 8.71, +IF1, 47.78 ± 7.35, IF1, 23.86 ± 8.34. Number of cristae per mitochondrion, control, 6.66 ±
1.05, +IF1, 15.85 ± 1.53; IF1, 1.45 ± 0.22. Number of cristae per 1 mm2, Control, 6.8 ± 0.14, +IF1, 9.2 ± 0.11, IF1, 2.32 ± 0.18, mean values ± SD obtained
from five different preparations of each transfection, **p < 0.005).20 Cell Metabolism 8, 13–25, July 2008 ª2008 Elsevier Inc.
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have a significant effect on cell death induced by deprivation
of oxygen and glucose. When cellular respiration is compro-
mised, the cell may either ‘‘allow’’ themitochondria to depolarize
and conserve cellular ATP, or to consume ATP in order to main-
tain the potential. The ‘‘choice’’ that is made may depend on the
glycolytic capacity of the cells. It is not immediately obvious
whether it may be ‘‘better’’ (in terms of survival) to allow mito-
chondria to depolarize, as this may promote release of proapop-
totic inducers and so trigger pathways to cell death. However,
IF1 seems to be significantly protective against ischemic injury,
suggesting that the preservation of ATP at the expense of poten-
tial is a viable strategy to achieve protection. That different tis-
sues or cell types clearly show different expression levels of
IF1 relative to the b subunit of the ATPase suggests that its func-
tional role may vary between tissues in ways that have not been
previously explored. Under any circumstances in which Dcm is
compromised, the ATPase will consume ATP as an inevitable
consequence of the bioenergetic properties of the enzyme.
This includes hypoxia/ischemia in the brain, heart, and kidney,
impaired respiratory complexes due to mutations of mitochon-
drial DNA, and many of the neurodegenerative diseases. Varia-
tion in IF1 expression level in different populations of cells may
therefore influence the extent of cell injury in different popula-
tions. We have shown that levels of IF1 determine levels of cell
death in response to oxygen and glucose deprivation. The de-
gree of protection conferred by upregulation is high (40% de-
crease in cell death). Further, increased ‘‘forward’’ activity of the
enzyme promoted by IF1 may also be protective, suggesting that
IF1 is a prosurvival protein. It will obviously be important to
establish its role in intact tissues in order to establish the role
of the protein in vivo.
The data presented here argue against a fixed stoichiometric
relationship between IF1 and ATPase levels. Thus, IF1 is variably
expressed in a variety of tissues relative to the expression level of
the b subunit of the ATPase. That overexpression of the protein
has a functional impact on the rate of ATP consumption (Figures
2A and 2B) or themaintenance ofDcm by the ATPase (ameasure
of its proton pumping activity, see Figure 1E) demonstrates that
there is room for increased functional interaction between
recombinant IF1 and the ATPase—i.e., that the ATPase is not al-
ready saturatedwith the protein.What seems to usmore remark-
able is the variation in expression level between cell types within
a given tissue. Astrocytes—cells with a high glycolytic capac-
ity—show low relative levels of IF1 expression compared to a
relatively high expression in adjacent neurons—cells that are
dependent on oxidative phosphorylation. These differences in
expression level dictate the response of the mitochondria of
these two populations of cells to hypoxia—the neuronal mito-
chondria depolarize rapidly while mitochondria in astrocytes
maintain Dcm through the activity of the ATPase (Figure 3). Tele-
ologically, one can argue that in astrocytes, with a high glycolytic
capacity and sparse mitochondria, it is possible to expend some
ATP to maintain Dcm, while in the neuron with dense mitochon-dria and a highly oxidative metabolism, it is safer to conserve
ATP and allow Dcm to collapse.
Interestingly, an expression system in which a GFP is ex-
pressed driven by the ATPIF1 promoter in transgenic mice in
the GENSAT project shows IF1 expressed selectively in neurons
in the mouse CNS (see http://www.gensat.org/imagenavigator.
jsp?imageID=36545), confirming in vivo our data in cell culture.
The protein is highly conserved through evolution: bacteria,
nematodes, and yeast all have IF1 equivalents, and so it clearly
plays an important role in mitochondrial and cell biology. Our
observations that IF1 gene expression dictates fundamental
aspects of mitochondrial homeostasis including mitochondrial
ultrastructure and definition of oxidative phosphorylation
suggest that IF1 plays a wider and more fundamental role in
mitochondrial and cell metabolism than previously thought.
The impact of IF1 on mitochondrial ultrastructure is remark-
able. There is much interest at present concerning proteins
that govern mitochondrial ultrastructure and their effect on apo-
ptotic cell death, but very few proteins that clearly perform such
a role have been identified (Pellegrini and Scorrano, 2007). It has
also long been speculated that the F1Fo-ATP synthase may play
a major role in determining cristae formation (Paumard et al.,
2002; Strauss et al., 2008), and this work now provides evidence
in mammals that changes in a protein which affects the degree
of F1Fo-ATP synthase dimerization (Garcia et al., 2006) alter
the formation of cristae.
Thus it is clear that IF1 plays an important role in the life of the
mitochondrion contributing both to resting cell metabolism and
to defining cellular responses to respiratory inhibition.
EXPERIMENTAL PROCEDURES
Cell Culture
Functional experiments were carried out using the immortalized cell lines:
HL-1, C2C12, and HeLa. C2C12 cells were cultured in MEM (GIBCO) supple-
mented with 10% FBS, 100 units/ml penicillin, and 25 mg/ml streptomycin.
HeLa cells were grown in DMEM (Life Technologies, Inc.) supplemented with
10% FBS, 100 units/ml penicillin, and 25 mg/ml streptomycin. Cells were
kept in T-75 (250 ml) Falcon flasks, and incubated at 37C in a 5%CO2 humid-
ified incubator. Once they reached 50%–60% confluence, cells were split and
cultured on coverslips, using phosphate buffer saline (PBS-Sigma D8662)
without Ca2+ or Mg2+ and porcine trypsin supplemented with 0.2g EDTA
(ethylenediaminetetraacetic acid) 1x solution (Sigma T3924).
Animals
Mice used were C57Bl6J. The organs were removed and freeze-clamp frozen
in liquid nitrogen. The animals were kept under conditions and the experiments
were conducted in accordance with the Animals (Scientific Procedures) Act
1986 published by the UK Home Office.
Imaging Mitochondrial Membrane Potential
For the majority of experiments, we used tetramethyl rhodamine methyl ester
(TMRM, 50 nM, Invitrogen) in ‘‘redistribution mode’’ (Duchen et al., 2003): the
dye was allowed to equilibrate and was present continuously. TMRM distrib-
utes between cellular compartments in response to different potentials and,
at concentrations <50 nM, the fluorescent signal shows a simple relationship
with the dye concentration, so that signal intensity maps to mitochondrial(B) In (i), native mitochondrial fractions from rat heart mitochondria were used as an internal standard for BN-PAGE, control (mt-GFP), and + IF1 HeLa cells. Stan-
dardization of the gel confirmed the localization of monomeric (600 kDa) and dimeric (1200 kDa) forms of the F1Fo-ATP synthase. In (ii), the ratio between
monomeric and dimeric form of the ATPase in control and +IF1 cells estimated by densitometry, showing that complex V in the dimeric state was 41.17% ±
7.14% in control and 80.20% ± 4.86% with +IF1 (**p < 0.005, means ± SD in three separate experiments).Cell Metabolism 8, 13–25, July 2008 ª2008 Elsevier Inc. 21
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Regulation of Mitochondrial Structure and Function by IF1potential. TMRM fluorescence intensity was quantified by removing all
background signal by ‘‘thresholding’’ and measuring the mean TMRM fluores-
cence intensity in the pixels containing mitochondria. Thus, the signal is inde-
pendent of mitochondrial mass and only reflects the dye concentration within
individual mitochondrial structures. Mitochondrial depolarization is seen as the
movement of dye from mitochondria into the cytosol.
We also used rhodamine 123 in ‘‘dequench’’ mode, whereby mitochondria
accumulate the dye to concentrations at which fluorescence is quenched.
Under these conditions, an increase in fluorescence signals mitochondrial
depolarization (Duchen and Biscoe, 1992). Rhodamine 123 (1 mM) was added
into the cultures for 20 min and then washed out. We have presented these
data normalized between 0, representing the resting rhodamine 123 fluores-
cence, and 100, representing the maximal increase in Rh123 fluorescence in
response to mitochondrial depolarization by 1 mM carbonyl cyanide 4-(trifluor-
omethoxy)phenylhydazone (FCCP), which was done at the end of every
experiment.
Cell Transfection
The transfection of cells seeded on sterile glass coverslips was carried out us-
ing Lipofectamine Reagent (Invitrogen 18324-012) according to the manufac-
turer’s protocol. For overexpression of IF1, cells were transfected with cDNA
for IF1 (Open Biosystems, Invitrogen MHS1010-73732) at a concentration of
1 mg/ml. For suppressing IF1 expression, the silencing RNA (siRNA) was used
at 0.3 mg/ml. This is an olignucleotide that targets the mRNA of IF1 (QIAGEN
S100908075) with the following sequence:
Sense: r (GUG UGC UAC UAA CAG AUA A) dTdT
Antisense: r (UUA UCU GUU AGU AGC ACA C) dAdG
Target sequence: CTG TGT GCT ACT AAC AGA TAA
The siRNA was cotransfected with Yellow Fluorescent Probe (EYFP) or
Cyanin Fluorescent Probe (ECFP) (Clontech.) to identify transfected cells.
Western Blot Analysis
Cells and homogenized organs of interest from mice were washed into 10 mM
PIPES buffer, pH 7.3, containing 3 mMNaCl, 100 mM KCl, 3.5 mMMgCl2, and
6%sucrose. They were broken by sonication for 33 5 s (MSE Sonyprep;MSE,
Crawley, Surrey, UK) in the presence of protease inhibitors (1 mM di-isopropyl
fluorophosphate, 0.2 mM phenylmethanesulfonyl fluoride, 1 mg/ml leupeptin,
and 1 mg/ml tosyl-lysine chloroketone) and the protein concentrations of
each sample determined with a Bio-Rad Protein Assay (Bio-Rad, Mu¨nchen,
Germany). Western blotting was carried out as previously described (Giblin
et al., 1999; Leaney et al., 2001). Samples were loaded onto SDS-PAGE gels
and after electrophoresis transferred to nitrocellulose. After blocking, blots
were probed with rabbit polyclonal affinity-purified antibodies against IF1
(1:2000, a generous gift from Prof. Sir John Walker) and ATPase b subunit
(1:1000, ab14730). An equal amount of protein for each sample was loaded
on two gels and treated separately with the primary antibody for IF1 and the
ATP synthase b subunit. The blots were then washed and incubated with
horseradish peroxidase-conjugated antirabbit and antimouse secondary anti-
bodies respectively (Amersham Biosciences, Piscataway, NJ). The enhancedchemiluminescence (ECL) system and exposure to film was used to visualize
the bands, taking a number of different exposures. Nonsaturating digital im-
ages were scanned and analyzed using Scion image as previously described
(Leaney et al., 2001). The mean pixel intensity is compared in each tissue on
the same blot for a particular antibody and the values plotted as a ratio be-
tween IF1 and the ATP synthase b subunit. The variation in the ratio reflects rel-
ative differences in the expression ratio and is not an absolute measurement of
stoichiometry. Western blotting of transfected C2C12 and HeLa cells was per-
formed to validate the manipulation of IF1 level of expression, probing samples
with GAPDH (Abcam, ab 8245) as standard.
Immunofluorescence Studies
Immunofluorescence staining was performed on cultures fixedwith coldmeth-
anol and permeabilized with sodium deoxycholate (4 mM in TBS) and Triton X-
100 (0.025% in TBS). The blocking solution contained 1% BSA and 10% each
of the normal sera from the animals in which the secondary antibodies were
raised (goat and donkey) in TBS. The primary antibodies used were mouse
anti-ATPase b subunit (1:1000) and rabbit anti-IF1 (1:2000). Secondary
anti-mouse FITC-conjugated (1:500; Abcam, Cambridge, UK) and anti-rabbit
cyanine 5 Rhodamine Red-X goat anti-rabbit IgG (Molecular Probes R-6394)
antibodies were used. Nuclei were stained with 0.01% 4,6-diamidino-2-phe-
nylindole HCl (DAPI; Sigma), and the coverslips were mounted using AF1 (Citi-
fluor, London, UK). Negative controls were performed by omission of primary
or secondary antibody.
Luciferase Measurements
Luminescence was measured in a custom-built luminometer made in collabo-
ration with Cairn Research (Faversham, Kent). Cells were perfused with KRB,
supplemented with 1 mM CaCl2 and 50 mM luciferin. The light output of a cov-
erslip of transfected cells ranged from 1,000-10,000 counts per second (cps)
with backgrounds lower than 50 cps. All compounds employed in the experi-
ments were tested for nonspecific effects on the luminescence—none were
observed.
[Mg2+]c Measurement
Cells were loaded for 30 min with 5 mM Mag-fura AM ester and 0.005% Plur-
onic in a HEPES-buffered salt solution (HBSS) composed (mM) of 156 NaCl, 3
KCl, 2MgSO4, 1.25 KH2PO4, 2 CaCl2, 10 glucose, and 10 HEPES; pH was ad-
justed to 7.35 with NaOH. Fluorescence measurements were obtained using
an epifluorescence inverted microscope. Light from a Xenon arc lamp passed
through a monochromator to provide excitation light alternately at 340 and
380 nm (Cairn Research, Kent, UK). Emitted fluorescence was reflected
through a 515 nm long-pass filter to a cooled CCD camera (Hamamatsu,
Orca ER). Images were analyzed using software from Andor (Belfast, UK).
Investigating Mitochondrial Morphology
Transfected HeLa cells grown on melanex plastic 36 hr after transfection were
identified by fluorescence microscopy and their localization marked on the
plastic. Cells were fixed with phosphate-buffered 2.5% glutaraldehyde with
0.1 M sodium phosphate for 1 hr. Then, they were treated with 1% osmiumFigure 5. IF1 Expression Level Influences Mitochondrial Metabolism
(A) Dcm was measured using TMRM (50 nM) in HeLa cells in which IF1 was genetically manipulated together with EYFP to identify transfected cells. Dcm was
reduced in +IF1 cells and increased in IF1 cells (i). Summary of mean values normalized to control (± SD) are shown in (ii). +IF1, 0.757 ± 0.119, IF1, 1.3 ±
0.152; n = 18, ***p < 0.001.
(B) Oligomycin normalized the differences in potential between these groups. Changes of Dcm in response to oligomycin are shown (i), and normalized average
values before and after oligomycin exposure in (ii) (mean normalized TMRM values relative to control of 1 were +IF1, 0.81 ± 0.02, IF1, 1.2 ± 0.01, ***p < 0.001;
after oligomycin, values were the following: control: 1.38 ± 0.26, n = 36; +IF1, 1.55 ± 0.20, n = 39, p = 0.255; IF1, 1.31 ± 0.04; n = 40, p = 0.092.
(C) Mitochondrial ‘‘redox index’’ was measured from NADH autofluorescence using NaCN and FCCP to normalize the NADH signal to maximal reduction and
oxidization (assigned values of 1 and 0 respectively). In (i), NADH redox index was more oxidized in +IF1 cells. Mean values of redox index (± SD) were the fol-
lowing: control, 0.57 ± 0.06, n = 55 cells and +IF1: 0.37 ± 0.08 (n = 24 cells, ***p < 0.001) and more reduced in IF1 cells, value of 0.69 ± 0.04 (n = 32 cells,
***p < 0.001). In (ii), oligomycin normalized the differences between populations (the values ± SD of redox index were the following: control, 0.62 ± 0.03, n = 70
cells; +IF1, 0.65 ± 0.02, n = 25 cells; IF1, 0.58 ± 0.06, n = 23 cells, p = 0.774 and p = 0.553, respectively).
(D) HeLa cells cotransfected with cyt-luc and mtGFP (control, black trace; i) or cyt-Luc and recombinant IF1 (gray trace, i) perfused with Luciferin (50 mM) were
treated with oligomycin, which caused a decrease in ATP that was faster and larger in +IF1 cells compared to controls. In (ii), values of the normalized lumines-
cence signal after 6 min of oligomycin challenge are summarized. Mean values ± SD were the following: control, 0.88 ± 0.04, n = 7; +IF1, 0.76 ± 0.07 (n = 8,
*p < 0.05, three different preparations on 3 different days of experiments).Cell Metabolism 8, 13–25, July 2008 ª2008 Elsevier Inc. 23
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ded with epon. Electron micrographs were taken with a 2 JEOL 1010 transmis-
sion electron microscope (TEM). Acquired images were analyzed using Image
J and ‘‘Lucida’’ (Kinetic Imaging) to characterize precise mitochondrial size
distributions and to threshold and binarise the images (see Figure S3), allowing
quantification of the volume of amitochondrion occupied by cristae as the pro-
portion of total pixels occupied by amitochondrion that were below the thresh-
old. The software was also used to define the number of cristae per mitochon-
drion and per 1 mm2.
Blue Native Gel Electrophoresis and Western Blot Analysis
of the Mitochondrial Fraction of HeLa Cells
Cells were washed twice with PBS, resuspended in the buffer containing
250 mM sucrose, 1 mM EGTA, 50 mM Tris-HCl, 1 mM DTT, and protease in-
hibitor cocktail at pH 7.4 and gently disrupted by 15 up-and-down strokes in
tight glass-glass homogenizer. The homogenate was centrifuged at 15003 g
for 5 min twice. The pellet containing mitochondria was washed with homog-
enization buffer and centrifuged again at 10,0003 g for 10 min. Mitochondrial
pellets were solubilized with 1.5 M aminocaproic acid, 50 mM Bis-Tris at pH
7.0 and 1% dodecylmaltoside. Samples were incubated on ice for 20–30
min and then centrifuged 20.0003 g for 15 min to remove unsolubilized mate-
rial. Protein concentration in the supernatant was determined by Bradford’s
method using Bio-Rad protein estimation kit. Supernatants containing protein
complexes were combined with 5% w/v suspension of Coomassie brilliant
blue G-250 in the 1.5 M aminocaproic acid, 50 mM Bis-Tris at pH 7.0 buffer
(adding 0.5 ml of Coomassie suspension to each 10 ml of supernatant). To carry
out Blue Native Electrophoresis (as a first dimension), samples were separated
on a big dimensional (1 mm/16 cm/20 cm) 4%–12% gradient acrylamide gel.
Mitochondria isolated from rat heart were used as an internal standard to see
the quality of separation in the first dimension and to calibrate the BN gel (in
kDa). One hundred and twenty micrograms of mitochondrial protein from
HeLa cells and thirty micrograms from rat heart were loaded on the gel. The
gel was incubated with a dissociating solution (1% SDS and 1% mercaptoe-
thanol) at 37C for 30 min, washed 10 times with water, stacked over a 10%
SDS-PA gel, separated, and transferred to the PVDF membrane, and the
membranes were immunoblotted against ATP synthase (1:5 000 mAb
OXPHOS cocktail kit from MitoSciences).
Signal intensity of monomeric and dimeric forms of ATP synthase was
calculated using GeneTools software from SynGene.
Oxygen-Glucose Deprivation
C2C12 and HeLa cells expressing EGFP as control or ±IF1 were deprived of
oxygen and glucose by replacing the culture medium by a glucose-free saline
composed of + (in mmol/L) 116 NaCl, 5.4 KCl, 0.8 MgSO4.7H2O, 1NaH2PO4.
2H2O, 26.2 NaHCO3, 0.01 glycine, and 1.8 CaCl2.2H2O, at pH 7.4. Cultures
were placed in an airtight chamber and equilibrated with a continuous flux of
5% CO2/95% N2 for 20 min, after which the deoxygenated and glucose-free
BSS was replaced with the pre-OGD culture medium. Cells were returned to
normoxic conditions for 30 min. Control sister culture plates were exposed
to oxygenated BSS containing 5.5 mmol/L glucose in normoxic conditions
during the same time period.
Analysis of Cell Death
Cells were incubated with PI (10 mM) and 1 mg/ml Hoechst 33258 for 15 min,
washed three times with PBS, and analyzed using a Uv-vis confocal Zeiss
510 CLSM microscope. Hoechst 33258 stains all nuclei, while PI stains only
cells with a disrupted plasmamembrane. Dead cells (PI positive) were counted
as a fraction of total nuclei. In each experiment, >100 cells were examined in
random fields fromR3 culture wells for each condition.
Statistical Analysis
All statistical analyses were performed using a two-tailed Student’s t test
assuming normal distributions with unequal variances.
SUPPLEMENTAL DATA
Supplemental Data include three figures and can be found with this article
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